IceCure Medical Receives 180-Day Nasdaq Extension to Regain Minimum Bid Price Compliance
ICCM is trading near its 52-week low of $0.223 (11% above the low).
Summary
IceCure Medical received a 180-day extension from Nasdaq to regain compliance with the minimum bid price rule, avoiding immediate delisting but signaling ongoing challenges.
Key Events · Corporate Governance and Compliance · ICCM
-
Nasdaq Compliance Extension Granted
IceCure Medical received a 180-day extension from Nasdaq to regain compliance with the minimum $1.00 bid price requirement, extending the deadline to November 9, 2026.
-
Previous Non-Compliance
The company failed to regain compliance during the initial 180-day period, which ended on May 11, 2026, after first being notified on November 12, 2025.
-
Potential Reverse Share Split
IceCure Medical indicated its intention to cure the deficiency, potentially by effecting a reverse share split if necessary.
-
No Immediate Delisting
The notification has no immediate effect on the listing or trading of the company's ordinary shares on the Nasdaq Capital Market.
Analysis · ICCM · Industrial Applications And Services
IceCure Medical has been granted a critical 180-day extension by Nasdaq to meet the minimum $1.00 bid price requirement, pushing the deadline to November 9, 2026. This extension provides a temporary reprieve from potential delisting, which would severely impact the company's visibility and liquidity, especially for a micro-cap company already facing a 'going concern' warning. The company's stated intention to potentially effect a reverse share split to cure the deficiency highlights the severity of the situation and could be viewed negatively by investors.
How filings like this one have moved
In the 30 days to Oct 21, 2026, 37.2% of the 984 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.83%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ICCM was trading at $0.25 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $16.3M. The 52-week trading range was $0.22 to $1.40. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.